Back to search
FDAFDA · Food and drugs·Recall number D-66295-001

0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake Forest, IL 60045

Published October 16, 2013 · Recall initiated: September 5, 2013

Summary

FDA records drug Class II recall D-66295-001, published October 16, 2013 and initiated September 5, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 187,150 vials; Lot: Lot 17-400-EV* and 17-401-EV * Note: the lot number may be followed by 01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; potential for vial breakage

What to do

Voluntary: Firm initiated · Letter

Get an email if BUPIVACAINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BUPIVACAINE HYDROCHLORIDE
Manufacturer
Hospira Inc.
Distributor
Nationwide and Guam and Abu Dhabi
Lot
Lot 17-400-EV* and 17-401-EV * Note: the lot number may be followed by 01
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake Forest, IL 60045 recalled?

Yes. FDA published recall D-66295-001 on October 16, 2013. Reported hazard: Lack of Assurance of Sterility; potential for vial breakage

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUPIVACAINE HYDROCHLORIDE.